Review proposes SFRP4–integrin interaction may restrain tumor angiogenesis
A 2026 review proposes that SFRP4 may inhibit tumor angiogenesis through integrin-linked disruption of Wnt–β-catenin signaling, but the supplied evidence ...
A 2026 review proposes that SFRP4 may inhibit tumor angiogenesis through integrin-linked disruption of Wnt–β-catenin signaling, but the supplied evidence ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine